Terms: = Kidney tumors AND PPFIBP1, L2, 8496, ENSG00000110841, hSGT2, hSgt2p AND Diagnosis
5 results:
1. Assessment of PD-L1 expression in patients with neuroblastoma and renal tumors.
Şener S; Poyraz A; Okur A; Pınarlı FG; Karadeniz C
Turk J Pediatr; 2021; 63(5):758-766. PubMed ID: 34738358
[TBL] [Abstract] [Full Text] [Related]
2. Diagnostic accuracy and safety of percutaneous MRI-guided biopsy of solid renal masses: single-center results after 4.5 years.
Cazzato RL; De Marini P; Auloge P; Leclerc L; Tricard T; Linder V; Jost M; Ramamurthy N; Lang H; Garnon J; Gangi A
Eur Radiol; 2021 Feb; 31(2):580-590. PubMed ID: 32851448
[TBL] [Abstract] [Full Text] [Related]
3. Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma.
Zhang X; Yin X; Zhang H; Sun G; Yang Y; Chen J; Zhu X; Zhao P; Zhao J; Liu J; Chen N; Wang J; Shen P; Zeng H
BMC Cancer; 2019 Apr; 19(1):360. PubMed ID: 30992011
[TBL] [Abstract] [Full Text] [Related]
4. Development of Response Classifier for Vascular Endothelial Growth Factor Receptor (VEGFR)-Tyrosine Kinase Inhibitor (TKI) in Metastatic Renal Cell Carcinoma.
Go H; Kang MJ; Kim PJ; Lee JL; Park JY; Park JM; Ro JY; Cho YM
Pathol Oncol Res; 2019 Jan; 25(1):51-58. PubMed ID: 28963640
[TBL] [Abstract] [Full Text] [Related]
5. Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression.
Duman S; Töz H; Aşçi G; Alper S; Ozkahya M; Unal I; Celik A; Ok E; Başçi A
Nephrol Dial Transplant; 2002 May; 17(5):892-6. PubMed ID: 11981080
[TBL] [Abstract] [Full Text] [Related]
